New cancer drug tested on beagle with view to curing prostate cancer

Hoover the beagle has undergone a revolutionary new method for treating prostate cancer – there’s only one difference, it’s forms part of a treatment usually reserved for humans.

The canine was injected with new anti-nanotherapy at the University of Queensland as part of a clinical trial aimed at eventually finding a cure for prostate cancer in humans.

Associate Professor Kristofer Thurecht, researcher at ARC Centre of Excellence for Bio-Nano Science at the University of Queensland, told Ross and John the procedure was a “perfect example” of testing new therapeutics after injecting the dog with nanoparticles.

“By validating our theraeutic in Hoover and working towards a cure for his cancer, it gives us a lot of information on how to better improve therapeutics for humans,” he said.

“(As we) work towards finding a cure for his cancer, it gives us a lot of information on how to better improve therapeutics for humans.”

Click PLAY to hear Associate Professor Kristofer Thurecht speak with Ross and John